From COVID-19 vaccines to Moderna's mRNA flu vaccine, using mRNA as medicine has shown promise. But before mRNA drugs can go ...

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.

This flu season, some people will have a choice between getting the standard flu shot or the new mRNA flu vaccine, according ...

After initially refusing to even review it, the US Food and Drug Administration (FDA) has approved Moderna's mRNA seasonal flu vaccine, the pharmaceutical company announced in a press release. Known ...

The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the same technology as many Covid-19 jabs. However, it’s unclear whether insurance ...

Postdoctoral fellow and co-first author Dongyoon Kim demonstrates some of the equipment used to craft the new ionizable lipids. [Bella Ciervo, Penn Engineering] The explosion of mRNA vaccines brought ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise. Those symptoms, which typically resolve within days, are the natural ...

Moderna's mRNA flu vaccine just cleared its biggest hurdle. On Wednesday, the FDA approved mFlusiva (formerly known as mRNA-1010) for adults 50 and older, marking the first mRNA-based flu shot ever ...

Erie-area residents 65 and older are needed for a clinical trial testing a new and potentially better flu vaccine.